期刊文献+

局部缓释血管内皮生长因子促进肠吻合口愈合的研究 被引量:4

Study of Accelerating Effect of Local Delayed Releasing Vascular Endothelial Growth Factor on Healing of Intestinal Anastomotic Stoma
原文传递
导出
摘要 目的探讨应用生物蛋白胶缓释血管内皮生长因子(VEGF)促进肠吻合口愈合的有效性。方法通过在兔盲肠穿孔建立腹腔感染的动物模型,12h后行肠切除及肠吻合。动物分成4组(每组32只),各组吻合口表面所涂试剂不同:生理盐水组、生物蛋白胶组、VEGF组及VEGF+生物蛋白胶组。于手术后第3、5、7及14天统计各组吻合口漏发生情况,测量未发生吻合口漏的动物的吻合口破裂压,检测吻合口组织羟脯氨酸含量及VEGF表达情况。结果生物蛋白胶组及VEGF组的吻合口漏总发生率低于对照组,但差异无统计学意义(P>0.05),而VEGF+生物蛋白胶组则明显低于对照组(P<0.05)。至术后第14天,VEGF+生物蛋白胶组的吻合口破裂压、吻合口组织羟脯氨酸含量及VEGF蛋白表达阳性细胞率(除VEGF组)均较其余3组明显升高(P<0.05,P<0.01)。结论应用生物蛋白胶局部缓释VEGF能够促进肠吻合口愈合,降低吻合口漏的发生率。 Objective To investigate the effect of local delayed releasing vascular endothelial growth factor(VEGF)on accelerating healing of intestinal anastomotic stoma.Methods An intra-abdominal infection modal of rabbit was established by artificial appendix perforation,and excision and anastomosis of terminal ileum were subsequently performed after 12h.The animals were divided into four groups(32for each group)with different reagents on anastomotic surface:control group,fibrin glue group(FG group),VEGF group,and VEGF+FG group.The incidence of stomal leak,anastomosic bursting pressure,hydroxyproline content,and expression of VEGF in cured stoma tissue were measured respectively on day 3,5,7and 14after operation.Results The total incidence rate of leakage was lower in FG group and VEGF group than that in control group,but there was no statistical significance(P0.05).The incidence rate was significantly lower in FG+VEGF group than that in control group(P0.05).On day 14postoperatively,the bursting pressure of anastomotic stoma,hydroxyproline content,and positive cell expression rate of VEGF protein(except VEGF group)were significantly increased in FG +VEGF group than those in other three groups(P0.05,P0.01).Conclusion Local delayed release of VEGF by fibrin glue can improve the healing of intestinal anastomotic stoma and reduce the incidence of stomal leak.
出处 《中国普外基础与临床杂志》 CAS 2010年第11期1141-1146,共6页 Chinese Journal of Bases and Clinics In General Surgery
关键词 血管内皮生长因子 生物蛋白胶 肠吻合 吻合口漏 Vascular endothelial growth factor Fibrin glue Intestinal anastomosis Stomal leak
  • 相关文献

参考文献26

二级参考文献92

  • 1[1]Senger DR, Galli SJ, Dvorak AM, et al.Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid [J]. Science, 1983; 219(4587)∶983
  • 2[2]Connolly DT, Heuvelman DM, Nelson R, et al.Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis [J]. J Clin Invest, 1989; 84(5)∶1470
  • 3[3]De Vries C, Escobedo JA, Ueno H, et al.The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor [J]. Science, 1992; 255(5047)∶989
  • 4[4]Terman BI, Dougher-Vermazen NM, Carrion ME, et al.Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor [J]. Biochem Biophys Res Commun, 1992; 187(3)∶1579
  • 5[5]Brock TA, Dvorak HF, Senger DR. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells [J]. Am J Pathol,1991; 138(1)∶213
  • 6[6]Namiki A, Brogi E, Kearney M, et al.Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells [J]. J Biol Chem, 1995; 270(52)∶31189
  • 7[7]Mukhopadhyay D, Tsiokas L, Sukhatme VP. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression [J]. Cancer Res,1995; 55(24)∶6161
  • 8[8]McNamara DA, Harmey JH, Walsh TN, et al.Significance of angiogenesis in cancer therapy [J]. Br J Surg,1998; 85(8)∶1044
  • 9[9]Samoto K, Ikezaki K, Ono M, et al.Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors [J]. Cancer Res,1995; 55(5)∶1189
  • 10[10]Saito H, Tsujitani S, Kondo A, et al.Expression of vascular endothelial growth factor correlates with hemotogenous recurrence in gastric carcinoma [J]. Surgery, 1999; 125(2)∶195

共引文献109

同被引文献78

  • 1栗力.下肢动脉硬化闭塞症术后再闭塞的腔内治疗[J].中国血管外科杂志(电子版),2014,6(2):68-70. 被引量:8
  • 2GU Yong-quan ZHANG Jian QI Li-xing YU Heng-xi LI Jian-xin LI Xue-feng GUO Lian-rui LUO Tao CUI Shi-jun WANG Zhong-gao.Surgical treatment of 82 patients with diabetic lower limb ischemia by distal arterial bypass[J].Chinese Medical Journal,2007(2):106-109. 被引量:16
  • 3Brown GC,Magargal LE,Schachat A,et al.Neovascular glaucoma.Etiologic considerations.Ophthalmology 1984;91(4):315-320.
  • 4Ho QT,Kuo CJ.Vascular endothelial growth factor:Biology and therapeutic applications.Int J Biochem Cell Biol 2007;39(7-8):1349-1357.
  • 5Ferrara N.Vascular endothelial growth factor:basic science and clinical progress.Endocr Rev 2004;25(4):581-611.
  • 6Adamis AP,Shima DT.The role of vascular endothelial growth factor in ocular health and disease.Retina 2005;25(2):111-118.
  • 7Tripathi RC,Li J,Tripathi BJ,et al.Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma.Ophthalmology 1998;105(2):232-237.
  • 8Kodjikian L.Neovascular glaucoma treatment in 2012:role of anti- VEGF agents.J Fr Ophtalmol 2013;36(5):461-465.
  • 9Kotecha A,Spratt A,Ogunbowale L,et al.Intravitreal bevacizumab in refractory neovascular glaucoma:a prospective,observational case series.Arch Ophthalmol 2011;129(2):14550.
  • 10Kazlauskas A.A new member of an old family.Nat Cell Biol 2000;2(5):E78-79.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部